Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024
Compare Profit and Loss Results of Medico Remedies
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
375.00
-225.00
-60.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
375.00
-225.00
-60.00%
Expenditure (Ex Depriciation)
Stock Adjustments
-5.00
1.00
-6.00
-600.00%
Raw Materials Consumed
113.00
166.00
-53.00
-31.93%
Power & Fuel Cost
2.00
17.00
-15.00
-88.24%
Employee Cost
6.00
56.00
-50.00
-89.29%
Operating Expenses
7.00
32.00
-25.00
-78.12%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
23.00
-17.00
-73.91%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
6.00
-6.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
135.00
332.00
-197.00
-59.34%
Operating Profit (PBDIT) excl Other Income
15.00
43.00
-28.00
-65.12%
Other Income
2.00
5.00
-3.00
-60.00%
Operating Profit (PBDIT)
17.00
48.00
-31.00
-64.58%
Interest
1.00
11.00
-10.00
-90.91%
Profit before Depriciation and Tax
16.00
37.00
-21.00
-56.76%
Depreciation
3.00
19.00
-16.00
-84.21%
Profit Before Taxation & Exceptional Items
13.00
17.00
-4.00
-23.53%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
17.00
-4.00
-23.53%
Provision for Tax
3.00
5.00
-2.00
-40.00%
Profit After Tax
10.00
11.00
-1.00
-9.09%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
32.00
152.00
-120.00
-78.95%
Profit Available for appropriations
42.00
164.00
-122.00
-74.39%
Appropriations
42.00
164.00
-122.00
-74.39%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.22
2.41
-1.19
-49.38%
Profit And Loss - Net Sales
Net Sales 150.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024
Profit And Loss - Interest
Interest 1.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 10.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024
